Trials / Conditions / Adenocarcinoma Esophagus
Adenocarcinoma Esophagus
7 registered clinical trials studyying Adenocarcinoma Esophagus — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Molecular Analysis of Gastric and OEsophageal Cancers STudy NCT06702384 | Royal Marsden NHS Foundation Trust | — |
| Recruiting | Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma NCT06044311 | Sakti Chakrabarti | Phase 2 |
| Withdrawn | Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma NCT05067842 | Medical College of Wisconsin | — |
| Active Not Recruiting | Induction FLOT With CROSS CRT for Esophageal Cancer NCT04028167 | University of Colorado, Denver | Phase 2 |
| Unknown | Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising NCT04818476 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Completed | Pembrolizumab in Refractory Advanced Esophageal Cancer NCT02971956 | Dana-Farber Cancer Institute | Phase 2 |
| Terminated | Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or Esophagus NCT02991547 | The Guthrie Clinic | — |